MEK1 mutations confer resistance to MEK and B-RAF inhibition.

Proceedings of the National Academy of Sciences of the United States of America
Caroline M EmeryLevi A Garraway

Abstract

Genetic alterations that activate the mitogen-activated protein kinase (MAP kinase) pathway occur commonly in cancer. For example, the majority of melanomas harbor mutations in the BRAF oncogene, which are predicted to confer enhanced sensitivity to pharmacologic MAP kinase inhibition (e.g., RAF or MEK inhibitors). We investigated the clinical relevance of MEK dependency in melanoma by massively parallel sequencing of resistant clones generated from a MEK1 random mutagenesis screen in vitro, as well as tumors obtained from relapsed patients following treatment with AZD6244, an allosteric MEK inhibitor. Most mutations conferring resistance to MEK inhibition in vitro populated the allosteric drug binding pocket or alpha-helix C and showed robust ( approximately 100-fold) resistance to allosteric MEK inhibition. Other mutations affected MEK1 codons located within or abutting the N-terminal negative regulatory helix (helix A), which also undergo gain-of-function germline mutations in cardio-facio-cutaneous (CFC) syndrome. One such mutation, MEK1(P124L), was identified in a resistant metastatic focus that emerged in a melanoma patient treated with AZD6244. Both MEK1(P124L) and MEK1(Q56P), which disrupts helix A, conferred cross-resi...Continue Reading

References

Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jul 6, 2002·Science·I Bernard Weinstein
Oct 3, 2003·Cancer Cell·G Steven Martin
Nov 13, 2003·Seminars in Oncology·Lee F AllenMark B Meyer
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John RinehartMark B Meyer
Nov 16, 2004·Nature Structural & Molecular Biology·Jeffrey F OhrenCharles A Hasemann
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Nov 8, 2005·Nature·David B SolitNeal Rosen
Jun 16, 2006·The New England Journal of Medicine·Moshe TalpazCharles L Sawyers
Jun 16, 2006·The New England Journal of Medicine·Hagop KantarjianOliver G Ottmann
Feb 13, 2007·Nature Genetics·Roman K ThomasLevi A Garraway
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ultan McDermottJeffrey Settleman
Feb 5, 2008·Cancer Research·William M LinLevi A Garraway
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·James TsaiGideon Bollag
Apr 17, 2008·Methods in Enzymology·Pablo Rodriguez-Viciana, Katherine A Rauen
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David F McDermottEvan Hersh
Jan 22, 2009·European Journal of Human Genetics : EJHG·Maria Lisa DenticiBruno Dallapiccola
Jan 24, 2009·Biochemistry·Thierry O FischmannVincent S Madison
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christine A PratilasNeal Rosen
Feb 13, 2013·Clinical and Experimental Dermatology·G W M Millington

❮ Previous
Next ❯

Citations

Aug 27, 2013·Current Oncology Reports·April K S Salama, Kevin B Kim
May 8, 2013·Drugs·Charlotte LemechHendrik-Tobias Arkenau
Jan 5, 2010·ACS Chemical Biology·Ratika Krishnamurty, Dustin J Maly
Aug 4, 2012·Cell Death and Differentiation·Y Shao, A E Aplin
Apr 16, 2011·Leukemia·L S SteelmanJ A McCubrey
Nov 26, 2010·Nature·Cory M JohannessenLevi A Garraway
Apr 18, 2013·Nature Communications·Il-Jin KimAllan Balmain
Dec 27, 2011·Nature Genetics·Sergey I NikolaevStylianos E Antonarakis
Nov 19, 2013·Nature Genetics·Joshua J WaterfallPaul S Meltzer
Apr 6, 2012·Nature Reviews. Cancer·Keith T FlahertyDavid E Fisher
Aug 11, 2010·Oncogene·M A Davies, Y Samuels
Oct 2, 2012·The New England Journal of Medicine·Keith T FlahertyJeffrey Weber
Jan 28, 2011·The New England Journal of Medicine·Ultan McDermottMichael R Stratton
Jul 4, 2012·Briefings in Functional Genomics·Jennifer L Bromberg-WhiteNicholas S Duesbery
May 9, 2012·Journal of Molecular Cell Biology·Jae-Kyung WonKwang-Hyun Cho
Dec 20, 2012·Journal of the National Cancer Institute·Michael P SmithClaudia Wellbrock
Sep 25, 2012·The American Journal of Dermatopathology·Ricardo HsiehSilvia V Lourenço
Mar 24, 2011·The Cancer Journal·Mario Sznol
Sep 30, 2010·Pigment Cell & Melanoma Research·Sigrid M C BroekaertBoris C Bastian
Dec 24, 2010·Pigment Cell & Melanoma Research·Marie C ZipserKeith S Hoek
Sep 15, 2011·Pigment Cell & Melanoma Research·Pablo Lopez-Bergami
Jan 18, 2012·Pigment Cell & Melanoma Research·Ken Dutton-Regester, Nicholas K Hayward
May 17, 2012·Science Signaling·Kris C WoodDavid M Sabatini
Mar 30, 2011·Cancer Research·Bingbing DaiJack A Roth
Sep 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Johannes M HeuckmannRoman K Thomas
Jan 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dennie T FrederickJennifer A Wargo
Jan 5, 2013·Cancer Discovery·Steven R WhittakerLevi A Garraway
Dec 12, 2012·The Journal of Clinical Investigation·Tiffany ChangKevin Shannon
Apr 2, 2013·The Journal of Clinical Investigation·Ethan V AbelAndrew E Aplin
Mar 2, 2013·Therapeutic Advances in Medical Oncology·Muhammad KhattakJames Larkin
Feb 13, 2010·Journal of Hematology & Oncology·Christophe Frémin, Sylvain Meloche
Mar 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nikhil WagleLevi A Garraway
Apr 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tanios Bekaii-SaabMiguel A Villalona-Calero
Jul 17, 2013·Neurosurgery·Shih-Shan Lang
Aug 11, 2012·PloS One·Brenden ChenHuifeng Niu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.